About

Given Bryan Supran’s leading role in two major M&A transactions for Pfizer recently, his inclusion here should come as little surprise. The sale of its global nutritional buiness to Nestlé, and the divestiture of its animal health business required ‘the technical skill of a top M&A and securities attorney with the managerial savvy of a seasoned executive’, which is how Paul Kinsella of Ropes & Gray describes Supran. He is very much a pioneer of the new paradigm of in-house counsel, leading his team in taking decisions and carrying out processes that might once have been the sole reserve of outside counsel, so much so that it’s been coined “the Pfizer approach.” As Kinsella puts it, ‘Bryan Supran’s career embodies the premise of the GC Powerlist’. Paul Schnell, of Skadden, Arps, Slate, Meagher and Flom LLP agrees: ‘He is held in the highest regard internally and by outside lawyers for his legal skills, intelligence, creativity and judgment’.